Skip to main content

A TAILWIND FOR INDIAN PHARMA SECTOR

  ~ ANISH


The Indian pharma industry is on a good growth path and is likely to be in the top global markets in value term by 2020, according to the PwC – CII report titled “India Pharma industry ". 

India is called the pharmacy of the world. The drugs and pharmaceuticals sector have attracted cumulative FDI inflow . The Indian pharmaceuticals market has characteristics that make it unique. First,  branded generics dominate, making up for 70 to 80 per cent of the retail market.  Second, local players have enjoyed a dominant position driven by formulation  development capabilities . In addition to this, patent expiry or loss of brand exclusivity is also expected to result in higher exports of generic drugs. 



 Indian pharma companies are likely to focus on development of specialty medicines or complex generics to augment their portfolio and increase share in world exports. India has been newsworthy as a result of its indigenous phar- maceutical industry selling low-cost AIDS cocktails to South Africa in direct competition with drugs manufactured by multinationals.  70% of the pharmacetical market has been controlled by the leading 250 companies. The government has control over the price and there is severe price competition. 70% of the country’s demand has been met by the pharmaceutical industry.

We are at 11% of the generics market, if we accelerate the journey to at least 17% of the demand and given our exposure to exports, there is significant opportunity for us to drive the formulation business . Each industry in any country has its own strength . The growth of this industry is expected greatly because there is increase in potential. India's pharma sector products are cost effective and has good manufacturing power as compared to other countries . The marketing and supply chain is on the upper side in India . The manifold ecosystem also scale up the sector .



It is expected that the increase in export or generic drugs to the developed market will provide wide scope to perform large scale clinical trails for indian pharma sector .

Comments

Popular posts from this blog

Significance of the “Developed Country” Tag for India

By Xeena Mehta The officials of the United States Trade Representative (USTR) uphold a list of countries that categorises countries as “developing”, “developed”, and “least-developed”. Countries that are classified as “developing” have permissions to export certain goods to the U.S. without being hit by heavy legal tariffs that are bind to be imposed on goods from “developed” countries. The “developing country” tag was originated by U.S. Trade Act of 1974, to aid poor countries develop faster. World Trade Organization also acceded to grant trade benefits to countries that were classified as poor. If noticed we can see that about two-thirds of countries that are members of the WTO classify themselves as “developing” countries and avail fore deals. Any such classification of whether a country is “developing” or not is entirely objective. While the economic progress achieved by India and China have achieved over the last few decades is seen as a valid reason to get rid of their s...

Changing Environment For Local Business In Sri Lanka; Government Initiates The Revolution

Local industries and businesses are the backbone of the economy of any country. Additionally, Sri Lankan Government defines a local company as one with a minimum ownership of 51% of a Sri Lankan. To help these companies grow, the Sri Lankan Finance Ministry has proclaimed a circular enlisting the priorities to the local companies. Moreover, this move from the government may bring some salient alterations in the condition of the local manufacturers. The government has also come with up steps that will augment the local industries across the different domains. These domains include IT sector, construction, etc. The circular, as issued by the government includes relevant documentation regarding sourcing of resources and products. Additionally, sources point towards the fact that the government is hoping to extend support to the domestic sector and help them grow. Besides, the major focus is on the three sectors- IT software and hardware, construction and furniture and allied products. Pos...

SECOND WAVE OF VIRUS LEFT INDIA’S HOSPITALS IN TROUBLE AS SHOTS RUN LOW.

India is facing a health crisis because of the second wave of the virus which is hitting high records. Hospitals around the country are facing a huge shortage of care beds and intensive drugs. From the wealthiest state Maharashtra to the most populated state Utter Pradesh there has been a shortage of hospital care beds and immunization centers which results in turning away people as they are running out of vaccines.  Maharashtra’s health minister Rajesh Tope has announced a strict weekend lockdown in order to control the situation. Mumbai has currently used up all but 3% of its intensive care hospital beds. Mr. Rajesh Tope has warned the state that they have three days’ worth of shots in stock and vaccination centers across the state are being forced to close down. Chief minister Punjab said that the Punjab’s vaccine will last another five days, urging the government to increase the supply. New Delhi -the capital of the country is also facing a lot of troubles due to the virus. At ...